SONM · DNA X, Inc.
$4.03
-0.06 (-1.35%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 19, 2026
The latest filing no longer states the doubt (first flagged May 20, 2026).
View the 10-Q filed Aug 19, 2026Market Cap
$5.83M
Shares
1.49M
Volume · Oct 5
3706
Avg daily vol (3M)
20.19K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.03
Open$4.06
Day$3.97–4.15
52W close$2.75–16.87
Avg vol 30d17K
Short int21K · 1.4% float · 2.3d
Short vol40%
Last earningsMay 11, 2021
DataJan 2020–Oct 2026
Filing10-Q · Aug 19
Up next
filed Aug 19, 2026
call held Mar 11, 2021
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.4%
Latest settlement · 2.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−5%
below
Price vs 50-day avg
+14%
above
RSI (14)
55
neutral
MACD trend
Positive
52-week position
9%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+24%
trailing
6-month return
+20%
trailing
YTD return
+28%
this year
Relative strength
+9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.41% of float · ▲ +0.1% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
9 holders — mid 3-yr range
Squeeze score
49
elevated · 0–100
Fundamentals
Revenue growth
−38%
Y/Y
Gross margin
17%
contracting
EPS growth
+78%
Y/Y
Free cash flow
$-23.7M
Balance sheet
$3.8M
net debt
Quant / Vol
risk profile
Volatility
127%
annualized · 1-yr
Max drawdown
−84%
past year
ATR
9.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 9, 2023
Revenue growth rates
· for the next three years
at least 50%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−5%
Neutral
Price vs 50-day avg
+14%
Bullish
RSI (14)
55
Neutral
MACD trend
Positive
Bullish
52-week position
9%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.41% of float · ▲ +0.1% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
9 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $4 · 9%
Range high $17
vs 200-day avg -5%
vs 50-day avg +14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Capital Markets — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SONM
this stock
DNA X, Inc.
|
$5.83M | +27.8% | -37.7% | — | 1.4% |
|
MS
Morgan Stanley
|
$308.32B | +7.1% | +5.5% | 15.9 | 0.9% |
|
GS
Goldman Sachs Group Inc
|
$272.38B | +1.6% | +8.9% | 14.4 | 2.4% |
|
SCHW
Schwab Charles Corp
|
$171.26B | -2.0% | +22.0% | 18.0 | 1.1% |
|
HOOD
Robinhood Markets, Inc.
|
$107.35B | +0.9% | +51.6% | 52.8 | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SONM | -7.5% | +24.2% | +20.2% | -11.8% | +27.8% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | -8.7% | +23.6% | +8.6% | -13.4% | +14.2% |